To broadly investigate the role of the inactive BAX dimer in cancer cells, we performed fractionation of cytosolic fractions of a diverse panel of hematological and solid tumor cell lines, including leukemia, lymphoma, colorectal and non-small lung cancer cell lines, with various genomic alterations. The gene discussed is BAX; the disease is leukemia.